209 related articles for article (PubMed ID: 28530090)
1. Drug-coated balloons for long lesions in peripheral arterial disease.
Li J; Parikh SA
J Cardiovasc Surg (Torino); 2017 Oct; 58(5):698-714. PubMed ID: 28530090
[TBL] [Abstract][Full Text] [Related]
2. 1-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery Disease: Evidence From the SFA-Long Study.
Micari A; Vadalà G; Castriota F; Liso A; Grattoni C; Russo P; Marchese A; Pantaleo P; Roscitano G; Cesana BM; Cremonesi A
JACC Cardiovasc Interv; 2016 May; 9(9):950-6. PubMed ID: 27151609
[TBL] [Abstract][Full Text] [Related]
3. Drug-eluting balloon catheters for lower limb peripheral arterial disease: the evidence to date.
Barkat M; Torella F; Antoniou GA
Vasc Health Risk Manag; 2016; 12():199-208. PubMed ID: 27274265
[TBL] [Abstract][Full Text] [Related]
4. In-stent restenosis management: the best is yet to come.
van den Berg JC
J Cardiovasc Surg (Torino); 2017 Aug; 58(4):508-517. PubMed ID: 28322039
[TBL] [Abstract][Full Text] [Related]
5. Drug-Coated Balloons for Complex Femoropopliteal Lesions: 2-Year Results of a Real-World Registry.
Schmidt A; Piorkowski M; Görner H; Steiner S; Bausback Y; Scheinert S; Banning-Eichenseer U; Staab H; Branzan D; Varcoe RL; Scheinert D
JACC Cardiovasc Interv; 2016 Apr; 9(7):715-24. PubMed ID: 27056311
[TBL] [Abstract][Full Text] [Related]
6. The role of drug-coated balloons in in-stent restenosis.
Andrassy M; Celik S; Andrassy J; Lichtenberg MK; Brodmann M
J Cardiovasc Surg (Torino); 2017 Aug; 58(4):501-507. PubMed ID: 28358184
[TBL] [Abstract][Full Text] [Related]
7. Prime time for drug eluting balloons in SFA interventions?
Brodmann M
J Cardiovasc Surg (Torino); 2014 Aug; 55(4):461-4. PubMed ID: 24941235
[TBL] [Abstract][Full Text] [Related]
8. Angioplasty with drug coated balloons for the treatment of infrainguinal peripheral artery disease.
Werner M
Vasa; 2016 Sep; 45(5):365-72. PubMed ID: 27351416
[TBL] [Abstract][Full Text] [Related]
9. Drug-eluting balloons in below the knee treatment.
VAN DEN Berg JC
J Cardiovasc Surg (Torino); 2016 Dec; 57(6):811-816. PubMed ID: 27654100
[TBL] [Abstract][Full Text] [Related]
10. Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain.
Zeller T; Brodmann M; Micari A; Keirse K; Peeters P; Tepe G; Scheinert D; Jaff MR; Rocha-Singh KJ; Li P; Schmahl R; Ansel GM;
Circ Cardiovasc Interv; 2019 Jan; 12(1):e007730. PubMed ID: 30630355
[No Abstract] [Full Text] [Related]
11. Optical coherence tomography: guided therapy of in-stent restenosis for peripheral arterial disease.
Lichtenberg MK; Carr JG; Golzar JA
J Cardiovasc Surg (Torino); 2017 Aug; 58(4):518-527. PubMed ID: 28382804
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel-coated versus plain old balloon angioplasty for the treatment of infrainguinal arterial disease in diabetic patients: the Belgian diabetic IN.PACT Trial.
Debing E; Aerden D; Vanhulle A; Gallala S; von Kemp K;
J Cardiovasc Surg (Torino); 2017 Aug; 58(4):528-534. PubMed ID: 27727202
[TBL] [Abstract][Full Text] [Related]
13. Drug-Coated Balloon Versus Plain Balloon Angioplasty for the Treatment of Femoropopliteal Artery Disease: An Updated Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Giacoppo D; Cassese S; Harada Y; Colleran R; Michel J; Fusaro M; Kastrati A; Byrne RA
JACC Cardiovasc Interv; 2016 Aug; 9(16):1731-42. PubMed ID: 27539695
[TBL] [Abstract][Full Text] [Related]
14. Drug-coated balloons in the lower limb.
Zeller T; Schmitmeier S; Tepe G; Rastan A
J Cardiovasc Surg (Torino); 2011 Apr; 52(2):235-43. PubMed ID: 21460774
[TBL] [Abstract][Full Text] [Related]
15. Promising role of drug-coated balloons in the tibial vessels?
Langhoff R; Behne A; Buschmann E
J Cardiovasc Surg (Torino); 2016 Oct; 57(5):667-76. PubMed ID: 27465390
[TBL] [Abstract][Full Text] [Related]
16. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.
Zeller T; Rastan A; Macharzina R; Tepe G; Kaspar M; Chavarria J; Beschorner U; Schwarzwälder U; Schwarz T; Noory E
J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582
[TBL] [Abstract][Full Text] [Related]
17. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease.
Scheinert D; Schmidt A; Zeller T; Müller-Hülsbeck S; Sixt S; Schröder H; Weiss N; Ketelsen D; Ricke J; Steiner S; Rosenfield K
J Endovasc Ther; 2016 Jun; 23(3):409-16. PubMed ID: 27117972
[TBL] [Abstract][Full Text] [Related]
18. Drug-coated balloon in peripheral artery disease.
Shanmugasundaram M; Murugapandian S; Truong HT; Lotun K; Banerjee S
Cardiovasc Revasc Med; 2019 Apr; 20(4):338-343. PubMed ID: 29730237
[TBL] [Abstract][Full Text] [Related]
19. Clinical Randomized Trial Evaluating Novel, Microcrystalline, and Biocompatible Polymer Paclitaxel-Coated Balloon for the Treatment of Femoropopliteal Occlusive Disease: The BIOPAC Trial.
Buszman PP; Nowakowski P; Milewski K; Orlik B; Żurakowski A; Ludyga T; Polczyk F; Dębiński M; Jelonek M; Kachel M; Gąsior M; Granada JF; Kiesz RS; Buszman PE
JACC Cardiovasc Interv; 2018 Dec; 11(23):2436-2438. PubMed ID: 30522679
[No Abstract] [Full Text] [Related]
20. 12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty.
Marmagkiolis K; Hakeem A; Choksi N; Al-Hawwas M; Edupuganti MM; Leesar MA; Cilingiroglu M
Catheter Cardiovasc Interv; 2014 Oct; 84(4):555-64. PubMed ID: 24740749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
